A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LHD / left heart disease

[Related PubMed/MEDLINE]
Total Number of Papers: 56
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LHD  (>> Co-occurring Abbreviation)
Long Form:   left heart disease
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Animal models of pulmonary hypertension due to left heart disease. PH, PH-LHD
2022 First-pass perfusion cardiovascular magnetic resonance parameters as surrogate markers for left ventricular diastolic dysfunction: a validation against cardiac catheterization. CMR, LV, LVEDP, PBVi, PCWP, PTB, PTT, RV, RVSVI
2022 Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications. Ipc-PH, PA, PAWP, PH, PVD, RV
2022 Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease. PH
2021 Left Heart Disease-Related Pulmonary Hypertension. PH
2021 Right atrial volume is a major determinant of tricuspid annulus area in functional tricuspid regurgitation: a three-dimensional echocardiographic study. AF, FTR, PH, RAVmax, RVEDV, TAA, TOF
2021 The assessment of left heart disease in patients with systemic sclerosis and pulmonary hypertension. HFpEF, PH, SSc-PAH
2021 Therapeutic Challenges and Emerging Treatment Targets for Pulmonary Hypertension in Left Heart Disease. PH
2020 Cardiopulmonary Hemodynamics in Pulmonary Hypertension and HeartFailure: JACC Review Topic of the Week. mPAP, PH, PVR
10  2020 Characteristics and Prognostic Associations of Echocardiographic Pulmonary Hypertension With Normal Left Ventricular Systolic Function in Patients ≥90 Years of Age. HR, NYHA, PH
11  2020 Elevated plasma endocan and BOC in heart failure patients decrease after heart transplantation in association with improved hemodynamics. BOC, HF, HT, PH
12  2020 Pulmonary Hypertension Due to Left Heart Disease-A Practical Approach to Diagnosis and Management. CpcPH, HF, IpcPH, PH
13  2020 Pulmonary Hypertension Due to Left Heart Disease: Diagnosis, Pathophysiology, and Therapy. PH
14  2020 Survival characteristics and prognostic importance of echocardiographic measurements of right heart size and function in dogs with pulmonary hypertension. CI, HR, PH, RV, TAPSE
15  2020 Understanding tricuspid valve remodelling in atrial fibrillation using three-dimensional echocardiography. AF, NS, RV, TA, TOE, TR
16  2019 Efficacy and Safety of the Use of Pulmonary Arterial Hypertension Pharmacotherapy in Patients with Pulmonary Hypertension Secondary to Left Heart Disease: A Systematic Review. HF, PAH, PH
17  2019 Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease. MetS, PAs, PH
18  2019 Pulmonary Edema Following Initiation of Parenteral Prostacyclin Therapy for Pulmonary Arterial Hypertension: A Retrospective Study. CTD, LOS, PAH, RAP
19  2018 Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component. PH, RV
20  2018 Fasudil preserves lung endothelial function and reduces pulmonary vascular remodeling in a rat model of end‑stage pulmonary hypertension with left heart disease. NO, PH
21  2018 In-depth haemodynamic phenotyping of pulmonary hypertension due to left heart disease. NO, PH, PVR
22  2018 Pulmonary hypertension due to left heartdisease. PH
23  2018 Pulmonary hypertension in Spanish patients with systemic sclerosis. Data from the RESCLE registry. ATA, dSSc, esPAP, ILD, PH, RHC, SSc
24  2018 Successful treatment of severe combined post- and pre-capillary pulmonary hypertension in a patient with idiopathic restrictive cardiomyopathy. DPG, LVAD, NO, PAP, PAWP, PH, PVR, RCM, RHC, RVAD, WU
25  2018 [Pulmonary hypertension – a common condition in left heart disease]. Cpc-PH, Icp-PH, PH
26  2017 "From right to left": The role of right heart catheterization in the diagnosis and management of left heart diseases. ERS, ESC, ISHL, PH, RHC
27  2017 Angiogenic and inflammatory biomarkers in the differentiation of pulmonary hypertension. PH
28  2017 Imatinib relaxes the pulmonary venous bed of guinea pigs. ET-1, IPL, PCLS, PDGF, PH, PVs
29  2017 Pulmonary hypertension and ventilation during exercise: Role of the pre-capillary component. EOB, PH, PVR
30  2017 Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes. DPG, Ipc-PH, PH, PH-LHD, PVR, WU
31  2017 Pulmonary Hypertension secondary to Left Heart Disease. ESC, HF, HFpEF, PH
32  2016 Determinants and prognostic implications of the negative diastolic pulmonary pressure gradient in patients with pulmonary hypertension due to left heart disease. Cpc-PH, DPG, PAWP, PVR
33  2016 Lung Capillary Stress Failure and Arteriolar Remodelling in Pulmonary Hypertension Associated with Left Heart Disease (Group 2 PH). PH
34  2016 Physiological Techniques and Pulmonary Hypertension - Left Heart Disease. PH
35  2016 Pulmonary Hypertension in Heart Failure Patients: Pathophysiology and Prognostic Implications. PH
36  2016 Pulmonary hypertension in patients with heart failure and preserved ejection fraction: differential diagnosis and management. HFpEF, PAH, PH
37  2016 Pulmonary Hypertension in the Era of Mechanical Circulatory Support. MCS, PH
38  2016 Recognizing Pulmonary Hypertension and Right Ventricular Dysfunction in Heart Failure. HF, PH, RVD
39  2016 Treatment of advanced group 2 PH. PH
40  2015 Criteria for diagnosis of exercise pulmonary hypertension. CO, mPAP, PH, PVD, TPR
41  2015 Left ventricular heart failure and pulmonary hypertension. HF, HFpEF, HFrEF, PH, RV
42  2015 Prognostic Factors for Survival in Pulmonary Hypertension Due to Left Heart Disease. DPG, NT-proBNP, NYHA, PH, PVR, RAP, TPG
43  2015 Pulmonary hypertension due to left heart disease: The prognostic implications of diastolic pulmonary vascular pressure gradient. DPG, HF, PH, PVD, RHC, TPPG
44  2015 Takayasu arteritis-associated pulmonary hypertension. ET-1, IPAH, PA, PH, TA
45  2015 Why there is a need to discuss pulmonary hypertension other than pulmonary arterial hypertension? PAH, PH
46  2015 [Pulmonary hypertension due to left heart diseases]. PH
47  2014 Impact of pharmacologic interventions--treating endothelial dysfunction and group 2 pulmonary hypertension. HF, pEF, PH
48  2014 Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort. MR-proADM, MR-proANP, MRI, NT-proBNP, PAH, PH, RHC, SSc
49  2014 Lung capillary injury and repair in left heart disease: a new target for therapy? HF, PH
50  2014 Predictors of hospitalisations for heart failure and mortality in patients with pulmonary hypertension associated with left heart disease: a systematic review. PH, PH-LHD
51  2013 Pressure reflection in the pulmonary circulation by echocardiography in patients with left heart disease indicates reactive pulmonary hypertension. PH, PR, ROC, RVOT
52  2013 Pulmonary hypertension associated with left heart disease. PAH, PH
53  2013 Pulmonary hypertension due to left heart diseases. PH
54  2012 Clinical significance of reactive post-capillary pulmonary hypertension in patients with left heart disease. CHF, CI, pc-PH, PVR
55  2011 Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies. PH
56  2010 Mast cells promote lung vascular remodelling in pulmonary hypertension. PH